Infectious Disease wRVU Compensation in 2026: Benchmarks, Hospital Consultation, and What to Ask Before You Sign

Infectious disease is one of the lowest-compensated specialties in medicine despite having one of the highest cognitive demands. Medscape 2024 confirmed ID alongside endocrinology and pediatrics in the bottom-tier compensation rankings. The structural reasons are well known: ID is largely consultative work without procedural revenue, hospital consultation generates lower per-encounter wRVU credit than direct admitting service, and antimicrobial stewardship work — increasingly essential to hospital systems — does not generate billable revenue. The countervailing reality is that ID physicians are in significant shortage, particularly post-pandemic, and that shortage gives individual ID physicians negotiating leverage that compensation data does not fully reflect.

If you are an ID physician evaluating a contract — finishing fellowship, switching health systems, or considering an academic versus community versus private practice model — here is what the 2026 market actually looks like and how to use the leverage you have.

What the 2026 infectious disease benchmarks actually are

Based on MGMA 2025 data, the median ID physician produces approximately 3,900 wRVUs annually at $56 per wRVU. Total compensation at the median runs $245,000-$285,000.

The 75th percentile ID physician produces around 5,100 wRVUs annually. The 90th percentile is 6,400 — typically reflecting either a high-volume hospital consultation practice or an HIV-focused ambulatory practice with significant continuity care.

ID is largely cognitive and not significantly affected by the 2026 CMS efficiency adjustment.

The three infectious disease contract traps

Antimicrobial stewardship work uncompensated. Hospital systems increasingly expect ID physicians to lead antimicrobial stewardship programs (ASP) — review of antibiotic prescriptions, education of other physicians, surveillance for resistance patterns, formulary recommendations. This work is essential to hospital quality and Joint Commission accreditation. It generates no billable revenue.

Many ID contracts include ASP responsibilities as part of base clinical responsibilities with no additional compensation or reduction in clinical productivity expectations. Fair contract language addresses this — either ASP work is compensated through an administrative stipend ($25,000-$60,000 annually depending on program size), or the wRVU threshold is reduced to account for the time spent on non-billable stewardship work.

Hospital consult coverage with no defined volume cap. ID consults can be heavy — particularly in hospitals with active oncology, transplant, or surgical services. Volumes of 8-15 new consults per day are not uncommon in busy academic centers. Many ID contracts handle consult volume with vague language and no defined cap.

Fair contract language defines a maximum new consult volume per day, with separate compensation for high-volume days or weeks.

Outpatient HIV continuity care that does not fit the wRVU framework. ID physicians who manage HIV outpatient panels often face a structural mismatch: HIV care requires frequent visits, complex medication management, lab review, and significant between-visit communication, but the wRVU credit per encounter is similar to general outpatient ID work. The result is that HIV-focused practices often produce lower wRVU totals than the time investment justifies.

Fair contract language addresses this by either reducing the wRVU threshold for HIV-focused practices or providing supplemental compensation for HIV continuity work.

What fair infectious disease contract language looks like

On the wRVU structure: a threshold at or below the 50th percentile (around 3,900 wRVUs) with a rate at or above $56/wRVU. Given the supply-demand imbalance in ID, ask for above-median rates.

On antimicrobial stewardship: explicit administrative stipend or wRVU threshold reduction for non-billable stewardship work.

On consult volume: defined maximum new consult volume per day with separate compensation for high-volume days.

On HIV practice: threshold reduction or supplemental compensation that accounts for the time investment of HIV continuity care.

What to ask before you sign

Four specific questions worth getting answered in writing before you commit to an infectious disease contract:

1. What is the per-wRVU rate, how does that compare to the MGMA 2025 median of $56/wRVU, and given the supply-demand imbalance in ID, can the rate be negotiated above median?
2. What antimicrobial stewardship responsibilities are part of this role, and is there separate administrative compensation or wRVU threshold reduction for that non-billable work?
3. What is the maximum new consult volume per day I will be assigned, and is there separate compensation for high-volume days?
4. If HIV continuity care is part of this role, how is the wRVU threshold or supplemental compensation structured to account for the time investment?

These are reasonable questions. The shortage of ID physicians gives you leverage that other specialties do not have. Most ID physicians do not use that leverage because they do not realize they have it.

Want to know how your specific infectious disease contract compares to these benchmarks? FairRVU runs the full analysis in 60 seconds — wRVU rate vs market, stewardship compensation analysis, consult volume review, and HIV practice evaluation. Your contract is permanently deleted after processing.